Harmonized Index of Consumer Prices: Pharmaceutical Products for European Union (27 Countries from 2020)
CP0611EU272020M086NEST • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
119.68
Year-over-Year Change
2.32%
Date Range
12/1/2000 - 6/1/2025
Summary
The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products tracks changes in the prices of medications and related healthcare items across the European Union. This metric is an important indicator of consumer price inflation and pharmaceutical market trends.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The HICP for Pharmaceutical Products is a component of the broader HICP, which measures changes in consumer prices for a basket of goods and services across the EU. This pharmaceutical-specific index provides insights into price dynamics within the European healthcare sector.
Methodology
The data is collected through surveys of consumer prices from participating EU member states.
Historical Context
Policymakers and economists use this HICP component to monitor pharmaceutical affordability and inform healthcare policy decisions.
Key Facts
- The HICP for Pharmaceutical Products is a component of the broader HICP index.
- The index covers a basket of consumer healthcare products across the EU.
- Policymakers use this metric to monitor pharmaceutical affordability.
FAQs
Q: What does this economic trend measure?
A: The Harmonized Index of Consumer Prices (HICP) for Pharmaceutical Products tracks changes in the prices of medications and related healthcare items across the European Union.
Q: Why is this trend relevant for users or analysts?
A: This metric provides insights into price dynamics within the European healthcare sector and is an important indicator of consumer price inflation and pharmaceutical market trends.
Q: How is this data collected or calculated?
A: The data is collected through surveys of consumer prices from participating EU member states.
Q: How is this trend used in economic policy?
A: Policymakers and economists use this HICP component to monitor pharmaceutical affordability and inform healthcare policy decisions.
Q: Are there update delays or limitations?
A: The data is subject to the standard update schedule and limitations of the broader HICP index.
Related Trends
Harmonized Index of Consumer Prices: Mainly Administered Prices for European Union (27 Countries from 2020)
APMAINEU272020M086NEST
Producer Prices Index: Economic activities: Manufacturing: Domestic for the European Union
EU28PIEAMP02GPM
Consumer Price Index: Harmonised prices: Housing, water, electricity, gas and other fuels (COICOP 04): Electricity, gas and other fuels for the European Union
EU28CPHP0405GYM
Harmonized Index of Consumer Prices: Personal Care for European Union (27 Countries from 2020)
CP1210EU272020M086NEST
Harmonized Index of Consumer Prices: Insurance Connected with the Dwelling for European Union (27 Countries from 2020)
CP1252EU272020M086NEST
Import Price Index by Origin (NAICS): Machinery Manufacturing for European Union
COEECZ333
Citation
U.S. Federal Reserve, Harmonized Index of Consumer Prices: Pharmaceutical Products for European Union (27 Countries from 2020) (CP0611EU272020M086NEST), retrieved from FRED.